| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 11/11/2010 | US20100286141 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways |
| 11/11/2010 | US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses |
| 11/11/2010 | US20100286070 Affinity tag |
| 11/11/2010 | US20100286069 Cationic peptide for delivering an agent into a cell |
| 11/11/2010 | US20100286068 Molecular markers of plant embryogenesis |
| 11/11/2010 | US20100286067 Glycoconjugation of polypeptides using oligosaccharyltransferases |
| 11/11/2010 | US20100286060 Specific binding agents of human angiopoeitin-2 |
| 11/11/2010 | US20100286049 Polycystic kidney disease-related gene and use thereof |
| 11/11/2010 | US20100286048 Albumin Fusion Proteins |
| 11/11/2010 | US20100286046 Modified h2 relaxin for tumor suppression |
| 11/11/2010 | US20100286025 Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| 11/11/2010 | US20100285988 Gamma-Secretase Substrates And Methods Of Use |
| 11/11/2010 | US20100285591 Cyclin d polynucleotides, polypeptides and uses thereof |
| 11/11/2010 | US20100285589 Generation of pluripotent cells from fibroblasts |
| 11/11/2010 | US20100285588 Apparatus and Methods for Cell Isolation |
| 11/11/2010 | US20100285587 Tissue Graft |
| 11/11/2010 | US20100285586 Method of producing a population of cells |
| 11/11/2010 | US20100285585 Method for extracellular matrix mediated differentiation and proliferation of stem cells |
| 11/11/2010 | US20100285584 Engineered cellular pathways for programmed autoregulation of differentiation |
| 11/11/2010 | US20100285583 Compounds and methods for inhibiting platelet aggregation |
| 11/11/2010 | US20100285582 Various human dental stem cells having a mineralization ability and the method for culturing them |
| 11/11/2010 | US20100285581 Solid Phase Cell Isolation and/or Enrichment Method |
| 11/11/2010 | US20100285580 Cardiac Conduction System (CCS) Progenitor Cells and Uses Thereof |
| 11/11/2010 | US20100285579 Preantral follicle derived embryonic stem cells |
| 11/11/2010 | US20100285578 Nucleic Acid Purification |
| 11/11/2010 | US20100285577 Isolation, Characterization and Propagation of Germline Stem Cells |
| 11/11/2010 | US20100285568 Recombinant factor x with no glycosylation and method for preparing the same |
| 11/11/2010 | US20100285541 Transaminase biocatalysts |
| 11/11/2010 | US20100285533 Culture media additive and process for using it |
| 11/11/2010 | US20100285529 Feline granulocyte macrophage colony stimulating factor proteins |
| 11/11/2010 | US20100285526 Compositions and Methods for Fusion Protein Separation |
| 11/11/2010 | US20100285521 Adipose tissue collection and pre-processing devices for use in liposuction procedure |
| 11/11/2010 | US20100285464 A conserved region of the hiv-1 genome and uses thereof |
| 11/11/2010 | US20100285451 Detection of sub-cellular compartment localization of a molecule using a reduced affinity enzyme complementation reporter system |
| 11/11/2010 | US20100285445 Chimeric construct of mungbean yellow mosaic india virus (mymiv) and its uses thereof |
| 11/11/2010 | US20100285202 Soybean Cultivar S080206 |
| 11/11/2010 | US20100285138 Compositions comprising nanoparticles and apoptotic agents and methods of use |
| 11/11/2010 | US20100285131 Fgf21 mutants and uses thereof |
| 11/11/2010 | US20100285112 Methods of delivering oligonucleotides to immune cells |
| 11/11/2010 | US20100285109 Truncated secretory aspartyl proteinase 2 |
| 11/11/2010 | US20100285107 Short nucleic acid molecule-mediated modulation of aurora b kinase expression and combinations for use in anticancer therapy |
| 11/11/2010 | US20100285104 Compositions and methods for the delivery of oxygen |
| 11/11/2010 | US20100285093 Methods and compositions for repair of cartilage using an in vivo bioreactor |
| 11/11/2010 | US20100285092 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers |
| 11/11/2010 | US20100285091 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers |
| 11/11/2010 | US20100285090 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers |
| 11/11/2010 | US20100285086 Biomimetic Extracellular Matrices |
| 11/11/2010 | US20100285073 a micro-rna family that modulates fibrosis and uses thereof |
| 11/11/2010 | US20100285072 Method for Producing Dendritic Cells |
| 11/11/2010 | US20100285058 Dna vaccine for treating or preventing cervical cancer comprising a gene encoding hpv protein |
| 11/11/2010 | US20100285049 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 11/11/2010 | US20100285048 Use of flagellin in the immunotherapy of yersinia pestis |
| 11/11/2010 | US20100285043 Mite antigenic rice |
| 11/11/2010 | US20100285037 Antibodies to cll-1 |
| 11/11/2010 | US20100285036 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same |
| 11/11/2010 | US20100285035 High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1 |
| 11/11/2010 | US20100285034 Method |
| 11/11/2010 | US20100285032 Estrogen receptor-related receptor gamma (err gamma) in bone and cartilage formation and methods and compositions relating to same |
| 11/11/2010 | US20100285027 Antibodies specific for human hepcidin |
| 11/11/2010 | US20100285026 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 11/11/2010 | US20100285023 Detecting cyp24 expression level as a marker for predisposition to cancer |
| 11/11/2010 | US20100285017 Matriptase protein and uses thereof |
| 11/11/2010 | US20100285014 Immunoglobulin fusion proteins |
| 11/11/2010 | US20100285009 Humanized anti-egfl7 antibodies and methods using same |
| 11/11/2010 | US20100285004 Anti-CD38 human antibodies and uses thereof |
| 11/11/2010 | US20100284995 Temperature sensitive mutants of matrix metalloproteases and uses thereof |
| 11/11/2010 | US20100284978 Cultures, products and methods using umbilical cord matrix cells |
| 11/11/2010 | US20100284977 Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters |
| 11/11/2010 | US20100284976 Compositions for the preparation of mature dendritic cells |
| 11/11/2010 | US20100284975 Polypeptides comprising fas activation and nkg2d-ligand domains |
| 11/11/2010 | US20100284973 Use of a L. Casei Strain For the Preparation of a Composition for Inhibiting Mast Cell Activation |
| 11/11/2010 | US20100284920 Uses of monoclonal antibody 8h9 |
| 11/11/2010 | US20100284916 Antibodies Against Human Cytomegalovirus (HCMV) |
| 11/11/2010 | US20100284915 Genes associated with chemotherapy response and uses thereof |
| 11/11/2010 | US20100284909 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 11/11/2010 | US20100284907 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells |
| 11/11/2010 | CA2761203A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability |
| 11/11/2010 | CA2760890A1 Anti-cd100 antibodies and methods for using the same |
| 11/11/2010 | CA2760876A1 Novel sugar transporters |
| 11/11/2010 | CA2760768A1 Lung tissue model |
| 11/11/2010 | CA2760099A1 Methods for selecting expanded stem cell populations |
| 11/10/2010 | EP2249157A1 Method for purifying at least one target substance to be detected |
| 11/10/2010 | EP2248910A1 Epitope synchronization in antigen presenting cells |
| 11/10/2010 | EP2248900A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 11/10/2010 | EP2248898A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 11/10/2010 | EP2248897A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 11/10/2010 | EP2248896A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 11/10/2010 | EP2248889A1 Reversibly immortalized cells as well as methods relating hetero |
| 11/10/2010 | EP2248888A1 Method of differentiation induction to osteoblasts |
| 11/10/2010 | EP2248887A1 A method for constructing human placental mesenchymal cells library which is suitable for clinical application |
| 11/10/2010 | EP2248826A1 Antibody directed against pcrv |
| 11/10/2010 | EP2248656A1 Methods for producing synthetic surfaces that mimic collagen coated surfaces for cell culture |
| 11/10/2010 | EP2247747A2 Cell culture article and screening |
| 11/10/2010 | EP2247719A1 Siva 2 stabilization |
| 11/10/2010 | EP2247718A1 Synthetic surfaces for culturing stem cell derived cardiomyocytes |
| 11/10/2010 | EP2247716A2 Synthetic surfaces for culturing cells in chemically defined media |
| 11/10/2010 | EP2247612A1 Siva 3, its preparation and use |
| 11/10/2010 | EP2247312A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 11/10/2010 | EP2247285A2 Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose |
| 11/10/2010 | EP2247181A1 Method for preserving sperm and applications thereof |